Theon International Shares Surge 76% Over the Year and Test Key Resistance
On Friday, March 13th, Theon International shows a significant increase, with its share price reaching 32.15 euros during the session, up by 3.21% from the previous day's close. This movement extends a bullish trend that has been ongoing for several weeks, with the stock gaining more than 7% over the past seven days. The stock is moving in a generally stable market environment, with the CAC 40 remaining virtually unchanged at 7,984 points during the session.
Today's Surge Brings Theon International Close to Key Resistance
Today's surge brings Theon International's share price to 32.15 euros, just shy of its identified resistance at 32.20 euros. This level is a critical threshold: a confirmed breach could pave the way for further appreciation, while a rejection at this point could temporarily slow the bullish momentum. The stock is now well above its 50-day and 200-day moving averages, positioned at 30.61 and 28.93 euros respectively, indicating a well-established upward trend in the medium and long term. The RSI, at 47, remains in the neutral zone, suggesting that the stock is not overheated despite the recent strong movement. It is also worth noting that the price has crossed the upper Bollinger band (32.03 euros), indicating increased buying pressure at the end of the week.
Annual Performance and Upcoming Financial Calendar
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Over the past year, Theon International has soared by 76%, with a three-month gain of 10.29%. This trajectory is accompanied by a beta of 0.31, indicating that the stock moves relatively independently from the overall market fluctuations. The monthly volatility, measured at 15.98%, remains moderate considering the magnitude of the gains recorded. On the financial calendar, the next key dates are April 30th for the annual report publication, followed by the first quarter 2026 revenue announcement on May 5th. These upcoming events will provide the market with an opportunity to match the current stock market dynamics with the operational achievements of the company specialized in imaging and night vision systems. Until these publications, the stock is trading close to its recent highs.
Strong H1 performance and positive momentum continuing into H2 2026 with further acceleration expected in Q4.
Risks mentioned
Integration of newly acquired businesses represents execution risk
Market expansion into high-growth adjacencies requires successful product development and market acceptance
Working capital absorption at 40% of LTM revenues indicates continued working capital pressure
Opportunities identified
Expansion into high-growth adjacencies increasing addressable market to nearly €8 billion
Integration of newly acquired businesses to drive future growth
Strong seasonal second half weighting supporting continued momentum into Q4 2026
Outlook / guidance
Expected revenue: 600 millions d'euros
Management commentary: THEON's Management team will also provide an update on FY 2026 and medium-term guidance during the webcast tomorrow. FY 2026 Guidance: Revenue c.€600 m; Adjusted EBIT Margin >26%; Capex €30 m; Medium-Term: Organic Growth >15%p.a.; Capex c. 4% of Revenue.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
